E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/24/2012 in the Prospect News Emerging Markets Daily.

ImPact Medical on roadshow for $135 million five-year secured notes

By Paul A. Harris

Portland, Ore., Sept. 24 - ImPact Medical BV is marketing a $135 million offering of unrated five-year second-lien secured notes, according to an informed source.

The Regulation S only deal is expected to price during the Oct. 1 week.

Knight Capital is the bookrunner.

The notes come with three years of call protection.

The company will consider an equity component to enhance the yield.

Proceeds will be used to acquire three Latin American medical device distribution companies and $43 million of EBITDA.

The issuer is a Dutch-based orthopedic and cardiovascular medical device distributor, which will be based in Atlanta. Its main operations are in Brazil.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.